Northern Trust’s Milestone Pharmaceuticals MIST Stock Holding History

Northern Trust’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$46.1K	Sell	38,779 -479	-1%	-$839	﹤0.01%	4256
2025 Q4	$79.3K	Hold	39,258	–	–	﹤0.01%	4181
2025 Q3	$78.5K	Sell	39,258 -13,743	-26%	-$24.2K	﹤0.01%	4189
2025 Q2	$103K	Hold	53,001	–	–	﹤0.01%	4105
2025 Q1	$42.4K	Sell	53,001 -5,107	-9%	-$10.2K	﹤0.01%	4248
2024 Q4	$137K	Buy	58,108 +30,772	+113%	+$52.8K	﹤0.01%	4094
2024 Q3	$41.5K	Sell	27,336 -448	-2%	-$652	﹤0.01%	4242
2024 Q2	$36.7K	Sell	27,784 -532	-2%	-$855	﹤0.01%	4257
2024 Q1	$50.7K	Sell	28,316 -3,654	-11%	-$5.93K	﹤0.01%	4225
2023 Q4	$53.4K	Buy	+31,970	New	+$86.8K	﹤0.01%	4229

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Northern Trust's MIST Position: Q1 2026 in Review

Northern Trust reduced its Milestone Pharmaceuticals (MIST) stake by 1.2% in Q1 2026, selling an estimated $839 and leaving 38,779 shares worth $46.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4256.

Northern Trust first reported a position in MIST in Q4 2023 and has held it in 10 quarters since. The position peaked at $137K in Q4 2024. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

Northern Trust held 38,779 shares of Milestone Pharmaceuticals worth $46.1K as of Q1 2026.
Northern Trust sold 479 Milestone Pharmaceuticals shares in Q1 2026, an estimated $839.
Milestone Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4256 holding.
Northern Trust first reported a position in Milestone Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
Northern Trust's Milestone Pharmaceuticals position peaked at $137K in Q4 2024.
86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.